News Releases
Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
March 29, 2016
Vancouver, British Columbia, March 29, 2016 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) is pleased to provide an update on its technology development and recent presentation at the PITTCON 2016 conference in Atlanta, Georgia. PITTCON is one of the world’s largest annual premier conference and expositions on laboratory science. Cannabix and University of Florida researchers (UF) were invited to present the state of the art technology at sessions focused on drugged driving and illicit drug detection. Dr. Jared Boock gave a talk titled “Detection of Tetrahydrocannabinol (THC) and Related Compounds in Human Breath Using High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS)”. The presentation outlined how Cannabix and University of Florida researchers have made significant headway toward the development of an innovative FAIMS-based instrument for the detection of THC in human breath. PITTCON also provided Cannabix with the opportunity to cultivate strategic alliances with groups interested in advancing the implementation of breath-based drug detection for law enforcement.
Cannabix management and University of Florida chemists have confirmed the ability to specifically detect THC at standard temperature and pressure using our unique FAIMS cell coupled with mass spectrometry (FAIMS-MS). We have successfully isolated THC and THC-related by-products in controlled simulated breath samples, with the current FAIMS-MS configuration demonstrating THC detection limits which are at least 10 times more sensitive than previously reported in the exhaled breath literature. The Company also reports that it has been evaluating the feasibility of detecting other volatile compounds of interest using FAIMS-MS with promising preliminary results for cocaine models in simulated breath samples.
Development of the Cannabix instrument is rapidly advancing. Many proprietary components, such as a high-voltage generator, non-radioactive ionization source, and array detector are being integrated with the novel FAIMS cell to provide the most technologically advanced FAIMS-based instrument in the world.
Dr. Raj Attariwala, Cannabix’s Chief Scientific Officer, states, “Development of a standalone FAIMS based device for trace detection of THC in breath is progressing well. With the expertise of the Yost lab at UF, we have demonstrated the unique ability to have a device which allows real time analysis of exhaled breath without any cumbersome extraction techniques. Our recent analysis of the presentations at PITTCON affirms our belief that Cannabix is developing one of the most advanced and sensitive real time THC specific breath detection devices for roadside use by law enforcement.”
Kal Malhi, President of Cannabix stated, “Our recent visit to the University of Florida and the presentations at PITTCON reaffirm our belief that Cannabix is developing the best technology in the field of detection of THC in exhaled breath. Our FAIMS-MS device is now recognized as a very accurate and highly sensitive device and we are moving quickly moving towards miniaturization of the bench top device. Agreements are in place with parts suppliers and parts required to build the portable device are now on order and we expect to have a portable FAIMS-MS device for field testing in the coming months.”
We seek Safe Harbor.
Disclaimer:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
